Company: MDXG
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001376339-25-000009
Chunk: 5

Company: MIMEDX GROUP, INC.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 8
Chunk 5
---
 income tax provision57,294 30,633 (19,747)Income tax provision (expense) benefit from continuing operations(15,296)36,806 (206)Net income (loss) from continuing operations41,998 67,439 (19,953)Income (loss) from discontinued operations, net of tax421 (9,211)(10,244)Net income (loss)$42,419 $58,228 $(30,197)Net income (loss) available to common stockholders from continuing operations$41,998 $55,796 $(26,533)Basic net income (loss) per common share:Continuing operations$0.29 $0.48 $(0.24)Discontinued operations0.00 (0.08)(0.09)Basic net income (loss) per common share:$0.29 $0.40 $(0.33)Diluted net income (loss) per common share:Continuing operations $0.28 $0.43 $(0.24)Discontinued operations0.00 (0.06)(0.09)Diluted net income (loss) per common share:$0.28 $0.37 $(0.33)Weighted average common shares outstanding - basic146,979,354 116,495,810 112,909,266 Weighted average common shares outstanding - diluted149,049,197 145,962,462 112,909,266 

See notes to the consolidated financial statements.

F- 5

MIMEDX GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands) Year Ended December 31, 202420232022Cash flows from operating activities:  Net income (loss) from continuing operations$41,998 $67,439 $(19,953)Adjustments to reconcile net income (loss) from continuing operations to net cash flows provided by (used in) operating activities of continuing operations:  Share-based compensation16,933 16,959 11,328 Deferred income tax provision12,472 (37,802)— Shares received in settlement of litigation(9,300)— — Amortization of intangible assets3,762 762 701 Depreciation2,279 2,665 3,345 Loss on